Skip to main content
  • Home
  • Memorial Sloan Kettering Cancer Center
Institutional profile

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center is one of the oldest and most respected cancer institutions in the world. It was founded in 1884 as New York Cancer Hospital and has since evolved into a major cancer treatment and research center with deep expertise across oncology, surgery, radiation therapy, pathology, immunology, and translational science.

  • Highest 2026 tier: Tier I
  • Specialty Hospitals
  • 2 ranking categories

Overview

Memorial Sloan Kettering Cancer Center is one of the oldest and most respected cancer institutions in the world. It was founded in 1884 as New York Cancer Hospital and has since evolved into a major cancer treatment and research center with deep expertise across oncology, surgery, radiation therapy, pathology, immunology, and translational science.

MSK’s institutional strength is rooted in its focused cancer mission. The center combines patient care with the Sloan Kettering Institute, clinical trials, molecular diagnostics, precision oncology, and advanced therapeutic development. Its disease-specific programs support specialized care across both common and rare cancers.

Memorial Sloan Kettering Cancer Center is included in 2 2026 ranking categories. Its highest classification is Tier I. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityMemorial Sloan Kettering Cancer Center
Founded1884
Institution typeSpecialty Hospitals institution
HeadquartersNew York, United States
Primary focusSpecialty Hospitals
Highest 2026 ranking tierTier I

Principal activities

MSK’s institutional strength is rooted in its focused cancer mission. The center combines patient care with the Sloan Kettering Institute, clinical trials, molecular diagnostics, precision oncology, and advanced therapeutic development. Its disease-specific programs support specialized care across both common and rare cancers.

Core capability

Specialty Hospitals

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

Specialty Hospitals

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

Memorial Sloan Kettering’s long-standing specialization, research depth, and international reputation make it one of the benchmark institutions in the specialty hospital sector.

Memorial Sloan Kettering Cancer Center is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier I.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. Memorial Sloan Kettering Cancer Center should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as Memorial Sloan Kettering Cancer Center. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationMemorial Sloan Kettering Cancer Center
HeadquartersNew York, United States
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Rankings and recognition

2026

Tier I

2026

Tier II

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 Specialty Hospitals 2026 — 2026 inclusion and tier classification.
  2. Healthcare Ranking — Top 30 Centers of Excellence 2026 — 2026 inclusion and tier classification.
  3. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  4. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  5. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: Specialty Hospitals

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status. Corrections supported by authoritative documentation may be submitted to The Economy Wiki.